- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Roche Pharma, Italy
Total 468 results
-
Seoul National University Boramae HospitalRoche Pharma AGCompletedChronic Hepatitis CKorea, Republic of
-
West German Study GroupSanofi; Roche Pharma AGTerminated
-
Ludwig-Maximilians - University of MunichRoche Pharma AGUnknownMetastatic Pancreatic AdenocarcinomaGermany
-
The Lymphoma Academic Research OrganisationRoche Pharma AGTerminatedChronic Lymphocytic Leukemia | Primary Central Nervous System Lymphoma | Diffuse Large B-cell Lymphoma | Indolent Non-hodgkin LymphomaFrance
-
Assistance Publique - Hôpitaux de ParisRoche Pharma AGCompletedGlioblastoma Multiforme | Primary Brain TumorFrance
-
Royal Marsden NHS Foundation TrustRoche Pharma AGCompletedMetastatic Colorectal CancerUnited Kingdom
-
The Netherlands Cancer InstituteRoche Pharma AG; AstraZenecaCompletedBreast CancerNetherlands
-
Lund University HospitalRoche Pharma AG; Sanofi-SynthelaboCompletedStomach Cancer | Colorectal Cancer | Pancreas Cancer | Gall Bladder Cancer | Bile Ductus CancerSweden
-
Ludwig-Maximilians - University of MunichRoche Pharma AGUnknown
-
Azienda Ospedaliero-Universitaria di ParmaMinistry of Health, ItalyRecruitingStroke | Hemiplegia | HemiparesisItaly
-
University Hospital FreiburgRoche Pharma AG; Genzyme, a Sanofi Company; Astellas Pharma GmbHCompletedDisorder Related to Renal TransplantationGermany
-
Association Aquitaine de Recherche Clinique en...Roche Pharma AG; Chugai Pharma FranceCompletedArthritis, Rheumatoid | Tocilizumab | T-Lymphocytes, Helper-InducerFrance
-
Institut CurieRoche Pharma AG; National Research Agency, FranceNot yet recruitingTriple Negative Breast CancerFrance
-
Ludwig-Maximilians - University of MunichBayer; Roche Pharma AGActive, not recruiting
-
Grupo Espanol de Tumores NeuroendocrinosRoche Pharma AG; IpsenActive, not recruitingAdenocarcinoma | Neuroendocrine Tumor | Pheochromocytoma | Paraganglioma | Anaplastic Thyroid CancerSpain
-
University College, LondonRoche Pharma AG; Cancer Research UKActive, not recruitingLymphomaNew Zealand, United Kingdom, Australia
-
Fundacion SEIMC-GESIDARoche Pharma AG; Dynamic Science S.L.Completed
-
University of British ColumbiaRoche Pharma AG; Health CanadaEnrolling by invitationCovid19 | Asymptomatic Shedding ViralCanada
-
Instituto Valenciano de Infertilidad, IVI VALENCIARoche Pharma AGCompletedInfertility | Controlled Ovarian HyperstimulationSpain
-
Universidad de ValparaisoGlaxoSmithKline; Roche Pharma AG; Aclin LaboratoryCompleted
-
Ohio State University Comprehensive Cancer CenterRoche Pharma AGTerminatedAdenocarcinoma | Tumors | Unknown Primary TumorsUnited States
-
SCRI Development Innovations, LLCRoche Pharma AG; Sanofi-SynthelaboCompletedNeoplasms, Unknown PrimaryUnited States
-
Karolinska University HospitalRoche Pharma AG; Addoz; Tele2Sverige ABCompletedCommunication | Medication Adherence | Medication Nonadherence | Compliance | Transplant; Failure, KidneySweden
-
University of North Carolina, Chapel HillRoche Pharma AGCompletedHepatitis C | Substance Use Disorders | Mental DisorderUnited States
-
Seoul National University HospitalRoche Pharma AG; SciClone PharmaceuticalsCompletedChronic Hepatitis BKorea, Republic of
-
Association Européenne de Recherche en OncologieRoche Pharma AGUnknownColorectal CancerFrance
-
Latin American Cooperative Oncology GroupRoche Pharma AG; OncoclínicasNot yet recruitingBreast Cancer | HER2-positive Breast CancerBrazil
-
Medical University of ViennaRoche Pharma AG; Allcyte GmbHRecruitingRefractory Acute Myeloid Leukemia | Advanced Lymphoma | Refractory Lymphoma | Refractory Leukemia | Refractory T-Cell LymphomaAustria
-
Ulrik LassenGlaxoSmithKline; Pfizer; Roche Pharma AGRecruitingNeoplasms | Cancer | Tumors | NeoplasiaDenmark
-
University of BirminghamRoche Pharma AG; Cancer Research UKRecruitingBreast CancerUnited Kingdom
-
Mario Negri Institute for Pharmacological ResearchRoche Pharma AGActive, not recruiting
-
Instituto Nacional de Cancerologia de MexicoRoche Pharma AGActive, not recruiting
-
SOLTI Breast Cancer Research GroupRoche Pharma AG; AmgenActive, not recruiting
-
Instituto Valenciano de Infertilidade de LisboaRoche Pharma AGCompletedInfertility, Female | First Trimester Spontaneous AbortionPortugal
-
Karoline KrauseRoche Pharma AGCompleted
-
Western Health and Social Care TrustRoche Pharma AGUnknown
-
Patrick Veit-HaibachRoche Pharma AGTerminatedMetastatic Colorectal CancerSwitzerland
-
University College, LondonRoche Pharma AG; Cancer Research UKCompletedLung CancerUnited Kingdom
-
Groupe Francophone des MyelodysplasiesRoche Pharma AG; Celgene CorporationCompleted
-
University of CincinnatiRoche Pharma AG; University of TennesseeCompletedAcute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant RecipientsUnited States, Canada
-
South Eastern European Research Oncology GroupRoche Pharma AGUnknownBreast Cancer | MetastasisCroatia
-
Gustave Roussy, Cancer Campus, Grand ParisRoche Pharma AGRecruiting
-
AIO-Studien-gGmbHRoche Pharma AG; Immodulon Therapeutics LtdRecruiting
-
Instituto Nacional de Cancerologia de MexicoRoche Pharma AGCompletedALK Gene Rearrangement Positive | Non-Squamous Non-Small Cell Neoplasm of LungMexico
-
Borstkanker Onderzoek GroepRoche Pharma AG; BOOG Study CenterActive, not recruiting
-
Intergroupe Francophone de Cancerologie ThoraciqueRoche Pharma AG; GFPCCompletedSmall Cell Lung CancerFrance
-
Friedemann PaulRoche Pharma AGActive, not recruitingMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveGermany
-
King's College LondonRoche Pharma AG; Medical Research CouncilCompletedKidney Transplantation | Graft Rejection | ImmunosuppressionUnited Kingdom
-
Centre Jean PerrinRoche Pharma AG; NanoString Technologies, Inc.Terminated
-
Molecular NeuroImagingRoche Pharma AG; Institute for Neurodegenerative DisordersCompletedAlzheimer's Disease (AD)United States